Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacodynamic Models: Overview

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

Pharmacokinetic Models: Overview

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...

Model Approaches for Pharmacokinetic Data: Physiological Models

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...

Model Approaches for Pharmacokinetic Data: Compartment Models

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The AI-native health science institution innovation theater vs. structural redesign.

npj health systems·2026

Same author

Transient receptor potential channel 5 knockdown alleviates sevoflurane-induced neural injury by repressing oxidative stress.

Irish journal of medical science·2026

Same author

Tubuloside A Mitigates Sepsis-Induced Splenic Injury in Mice by Suppressing NOX4-Associated Oxidative Stress, Inflammation, Apoptosis, and Mitochondrial Dysfunction.

Journal of ethnopharmacology·2026

Same author

Innovation trajectory of Software as a Medical Device: Evidence from the US FDA-approved products.

Digital health·2026

Same author

Mild photothermal therapy ameliorates neurogenic bladder after sacral spinal cord injury via multi-target effects.

Materials today. Bio·2026

Same author

Clinicopathological and molecular characterization of HPV-associated cervical poorly cohesive carcinoma: a rare aggressive entity.

The journal of pathology. Clinical research·2026

Search research articles

Related Experiment Video

Updated: May 26, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Medication Reconciliation: Work Domain Ontology, prototype development, and a predictive model.

Eliz Markowitz¹, Elmer V Bernstam, Jorge Herskovic

¹School of Biomedical Informatics, The University of Texas Health Science Center at Houston, TX, USA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium

|December 24, 2011

Summary

This summary is machine-generated.

Developing a medication reconciliation (MR) tool using a Work Domain Ontology (WDO) significantly improves user efficiency. This approach reduces cognitive load and task completion time, enhancing patient safety in healthcare settings.

Related Experiment Videos

Last Updated: May 26, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Area of Science:

Health Informatics
Human-Computer Interaction
Patient Safety

Background:

Medication errors are a significant concern in healthcare, often stemming from administration inaccuracies.
Effective medication reconciliation (MR) tools are crucial for mitigating these errors.
Current MR tools may not adequately address the complexities of the medication reconciliation process.

Purpose of the Study:

To develop a successful Medication Reconciliation (MR) tool by building a Work Domain Ontology (WDO) for the MR process.
To create an MR tool prototype based on WDO principles and standard interface design.
To evaluate the efficiency of the WDO-based MR tool prototype compared to existing systems.

Main Methods:

Developed a Work Domain Ontology (WDO) to abstract the MR task from work context and technology.
Created a prototype MR tool adhering to the WDO and user interface guidelines.
Conducted a Keystroke-Level Model (KLM) analysis comparing the prototype with two existing MR tools for three distinct tasks.

Main Results:

The WDO-based MR tool prototype required the fewest mental operations.
The prototype demonstrated the fewest steps for task completion.
The prototype achieved task completion in the least amount of time compared to legacy systems.

Conclusions:

A medication reconciliation tool developed using a Work Domain Ontology improves user efficiency.
Implementing WDO principles and adhering to user interface guidelines reduces cognitive load for healthcare professionals.
This approach offers a promising strategy for enhancing the safety and effectiveness of medication reconciliation.